Back
Ligand Pharmaceuticals Stock Price Chart
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Buy
59
LGND
Ligand Pharmaceuticals
Last Price:
103.41
Seasonality Move:
1.98%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- The current trend is moderately bullish and LGND is experiencing selling pressure, which indicates risk of future bearish movement.
Ligand Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.21 | Buy |
| 20-day SMA: | 104.03 | Buy |
| 50-day SMA: | 102.27 | Buy |
| 200-day SMA: | 82.18 | Buy |
| 8-day EMA: | 103.77 | Buy |
| 20-day EMA: | 103.34 | Buy |
| 50-day EMA: | 100.02 | Buy |
| 200-day EMA: | 85.85 | Buy |
Ligand Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 53.91 | Buy |
| Chaikin Money Flow: | -71929 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.09 - 105.39) | Buy |
| Bollinger Bands (100): | (80.32 - 103.2) | Buy |
Ligand Pharmaceuticals Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ligand Pharmaceuticals Stock
Is Ligand Pharmaceuticals Stock a Buy?
- Ligand Pharmaceuticals share price is 104.26 while LGND 8-day simple moving average is 103.21, which is a Buy signal.
- The stock price of LGND is 104.26 while Ligand Pharmaceuticals 20-day SMA is 104.03, which makes it a Buy.
- Ligand Pharmaceuticals 50-day simple moving average is 102.27 while LGND share price is 104.26, making it a Buy technically.
- LGND stock price is 104.26 and Ligand Pharmaceuticals 200-day simple moving average is 82.18, creating a Buy signal.
LGND Technical Analysis vs Fundamental Analysis
Buy
59
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy or a Sell?
-
Ligand Pharmaceuticals stock is rated a Buy
The current Ligand Pharmaceuticals [LGND] share price is $104.26. The Score for LGND is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Ligand Pharmaceuticals Stock Info
Market Cap:
1.9B
Price in USD:
104.26
Share Volume:
91.56K
Ligand Pharmaceuticals 52-Week Range
52-Week High:
112.13
52-Week Low:
49.24
Buy
59
Ligand Pharmaceuticals (LGND)
is a Buy
Ligand Pharmaceuticals Share Price Forecast
-
What is the Ligand Pharmaceuticals stock price today?
The Ligand Pharmaceuticals stock price is 104.26 USD today. -
Will LGND stock go up or go down?
Ligand Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Ligand Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ligand Pharmaceuticals is not overvalued.
Is Ligand Pharmaceuticals Stock a Buy?
- Ligand Pharmaceuticals share price is 104.26 while LGND 8-day exponential moving average is 103.77, which is a Buy signal.
- The stock price of LGND is 104.26 while Ligand Pharmaceuticals 20-day EMA is 103.34, which makes it a Buy.
- Ligand Pharmaceuticals 50-day exponential moving average is 100.02 while LGND share price is 104.26, making it a Buy technically.
- LGND stock price is 104.26 and Ligand Pharmaceuticals 200-day simple moving average is 85.85, creating a Buy signal.
Fundamental Analysis of Ligand Pharmaceuticals
Is Ligand Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.72 per share, an increase next quarter of $0.29 per share, an increase this year of $0.04 per share, and an increase next year of $0.86 per share.
Technical Analysis of Ligand Pharmaceuticals
Should I short Ligand Pharmaceuticals stock?
- LGND Moving Average Covergence Divergence (MACD) indicator is 0.74, suggesting Ligand Pharmaceuticals is a Buy
- Ligand Pharmaceuticals Relative Strength Index (RSI) is 53.91, which suggest Ligand Pharmaceuticals is overbought
- The Bollinger Bands (25) for Ligand Pharmaceuticals is (102.09 - 105.39), which suggest Ligand Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Ligand Pharmaceuticals is (80.32 - 103.2), which suggest Ligand Pharmaceuticals is a Buy
* Ligand Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.